arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

iRhythm Holdings, Inc.

IRTC
$110.42 ▼ -0.03 (-0.03%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
46 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

iRhythm Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.6B
Dividend Yield
Revenue Growth 20.1%
Op. Margin -1.1%
ROIC -1.4%
FCF / Share $1.14
Trailing P/E
Price / Book 19.6x
FCF Yield 1.0%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$224.17M
↑ +20.1%
Net Income Profit after all expenses
$-13.93M
↑ +54.6%
Operating Margin Operating profit as % of sales
-1.1%
↑ +86.0% 17th
FCF / Share Free cash flow per share
$1.14
↑ +212.1%
Long-Term Debt Long-term obligations
$34.95M
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
27
Returns
24
Financial Health
35
Cash Quality
11

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 46 quarters